Alterations in endothelin receptors following hemorrhage and resuscitation by centhaquin
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- MID WESTERN UNIVERSITY BIRENDRANAGAR
- Publication Date
- 2021-03-09
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
[0001] Cross References to Related Applications
[0002] This application claims priority under 35USC §119(e) to U.S. Provisional Patent Application No. 62 / 666,675, filed May 3, 2018, and Indian Application No. 201841019588, filed May 25, 2018, the disclosures of which are incorporated by reference in their entirety Incorporated into this article. technical field
[0003] The present disclosure relates to methods and compositions for treating or preventing renal injury or failure comprising administration of endothelin B (ET B ) receptor agonists and / or alpha 2 Adrenergic agent.
[0004] Incorporation by reference of electronically submitted materials
[0005] As a separate part of this disclosure, this application contains a Sequence Listing in computer readable form (Filename: 50000A_Seqlisting.txt; Size: 673 bytes; Created: May 2, 2019), which is hereby incorporated by reference in its entirety. Background technique
[0006] Hemorrhagic shock often results in inadequa...